Allay Therapeutics Appoints Nicole Vitullo to Board of Directors

SAN JOSE, Calif.–(BUSINESS WIRE)–Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the appointment of Nicole Vitullo, venture partner at Arboretum Ventures, to its board of directors. “We’re thrilled to have Nicole join the Allay board and appreciate the continued…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks